AOPT Plus Collagen May Ease Rosacea - Summary - MDSpire
From the Journals

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks

  • By

  • Andrea Surnit

  • May 13, 2026

  • 3 min

Share

A randomized controlled trial revealed that combining recombinant human type III collagen dressings with advanced optimal pulse technology (AOPT) leads to significant improvements in erythema, lesion severity, skin barrier integrity, and patients' quality of life in those suffering from rosacea. Conducted on 150 participants aged 18–50 at The First Affiliated Hospital of Soochow University between May 2022 and May 2023, the study found an 89.3% response rate in the combination group compared to 77.3% for AOPT alone. Notably, recurrence was lower in the combination therapy group, suggesting enhanced treatment efficacy.

Original Source(s)

AOPT Plus Collagen May Ease Rosacea

  • by Andrea Surnit

  • May 13, 2026

Related Content

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.